Author:
Dreolini Lisa,Cullen Mark,Yung Eric,Laird Lawrence,Webb John R.,Nelson Brad H.,Hay Kevin A.,Balasundaram Miruna,Kekre Natasha,Holt Robert A.
Funder
BioCanRx
Biotherapeutics for Cancer Treatment
Networks of Centres of Excellence
Canada Foundation for Innovation
BC Cancer Foundation
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference19 articles.
1. Mycoplasma contamination of cell cultures: incidence, sources, effects, detection, elimination, prevention;Drexler;Cytotechnology,2002
2. The scope of mycoplasma contamination within the biopharmaceutical industry;Armstrong;Biologicals,2010
3. Mycoplasma pneumoniae in the immunocompromised host: a case series and review of literature;Yacoub;Infect. Dis. Clin. Pract.,2016
4. Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient;MacKenzie;Int. J. Infect. Dis.,2010
5. Bloodstream infection due to Mycoplasma arginini in an immunocompromised patient;Watanabe;J. Clin. Microbiol.,2012
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献